Abiopharma

10x Genomics - Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology

(19% Negative) Exagen Inc (XGN) Reports Q1 2026 Financial Results

(70% Positive) Masimo Corporation (MASI) Reports Q1 2026 Financial Results

Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug CandidateEntolimod™ And Achieves Reproducible Yields, Potency and Purity

Masimo - Masimo Announces Select Preliminary 2025 Financial Results

(78% Neutral) Healthequity Inc (HQY) Announces Business Combination

Press Release: AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause

(10% Negative) Jazz Pharmaceuticals plc (JAZZ) Announces Business Combination

(10% Negative) Ocuphire Pharma Inc. (OCUP) Announces Business Combination

(85% Positive) CONMED Corporation (CNMD) Reports Q1 2026 Financial Results

(99% Neutral) Zimmer Biomet Holdings Inc (ZBH) Announces Executive Changes

(90% Positive) Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE)) (AGLE) Announces Enrollment Update for trial Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Medtronic Diabetes announces FDA clearance for MiniMed Go™ Smart MDI system featuring Instinct sensor made by Abbott

Oncolytics Biotech® Announces Updated Clinical Data from GOBLET Cohort 4 Demonstrating Activity of Pelareorep Plus Atezolizumab in Third-Line Anal Cancer

Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships